BIOX Bioceres Crop Solutions Corp. - Ordinary Shares
NASDAQ · Chemicals · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Nov 10, 2025
$0,34
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$0,30rendah 52m
$2,19tinggi 52m
P/E
-5.1
EPS
$-0.88
Pendapatan
$335M
lencana Anda
Rentang 52M
$0–$2
Peringkat Analis
HOLD
Target Harga
·
P/E
-5.1
ROE
-19.1%
Margin Laba Bersih
-16.5%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
BIOX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$0.34
P/E
-5.1
EPS
$-0.88
Pendapatan
$335M
ROE
-19.1%
Rentang 52M
$0–$2
BIOX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$335M2016-12-31 → 2025-06-30
EPS$-0.882018-06-30 → 2025-06-30
Arus Kas Bebas$44M2019-06-30 → 2025-06-30
Margin bersih-16.5%2019-06-30 → 2025-06-30
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | BIOX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -5.1rata-rata 5T ≈9.1 | ≈9.1 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | BIOX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Gross Margin (Margin Kotor) | 39.3%rata-rata 5T ≈40.8% | ≈40.8% | · | · | |
| Operating Margin (Margin Operasi) | -0.67%rata-rata 5T ≈10.4% | ≈10.4% | · | · | |
| EBITDA Margin (Margin EBITDA) | -0.67%rata-rata 5T ≈10.4% | ≈10.4% | · | · | |
| Pretax Margin (Margin Sebelum Pajak) | -17.2%rata-rata 5T ≈-0.24% | ≈-0.24% | · | · | |
| Net Profit Margin (Margin Laba Bersih) | -16.5%rata-rata 5T ≈-3.3% | ≈-3.3% | · | · | |
| ROA | -6.9%rata-rata 5T ≈-1.4% | ≈-1.4% | · | · | |
| ROE | -19.1%rata-rata 5T ≈-5.7% | ≈-5.7% | · | · | |
| ROIC | -0.86%rata-rata 5T ≈-0.41% | ≈-0.41% | · | · |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | BIOX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Current Ratio (Rasio Lancar) | 0.9rata-rata 5T ≈1.2 | ≈1.2 | · | · | |
| Quick Ratio (Rasio Cepat) | 0.1rata-rata 5T ≈0.6 | ≈0.6 | · | · | |
| Interest Coverage (Cakupan Bunga) | -0.1rata-rata 5T ≈1.6 | ≈1.6 | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | BIOX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.4rata-rata 5T ≈0.6 | ≈0.6 | · | · | |
| Inventory Turnover (Perputaran Persediaan) | 1.9rata-rata 5T ≈2.1 | ≈2.1 | · | · | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$446.2K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun
Rasio Pembayaran Dividen-0.13%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-251.0%
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 31 Maret 2026 | $-0.16 | $-0.05 | -213.7% | |
| 31 Des. 2025 | $-0.08 | $0.07 | -212.0% | |
| 30 Sep. 2025 | $-0.12 | $-0.07 | -62.2% | |
| 30 Juni 2025 | $-0.70 | $0.08 | -1015.0% | |
| 31 Maret 2025 | $-0.02 | $-0.15 | 86.9% | |
| 31 Des. 2024 | $0.01 | $0.09 | -89.8% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $335M | $465M | $420M | $335M | $210M | $173M | $161M | $134M | |
| Cost of Revenue | $203M | $278M | $235M | $208M | $119M | $94M | $87M | $77M | |
| Gross Profit | $132M | $187M | $185M | $126M | $91M | $80M | $74M | $56M | |
| R&D Expense | $15M | $17M | $15M | $7M | $6M | $4M | $4M | $4M | |
| SG&A Expense | $123M | $124M | $113M | $77M | $48M | $38M | $39M | $35M | |
| Operating Income | $-2M | $46M | $54M | $40M | $38M | $39M | $32M | $16M | |
| Interest Expense | $29M | $27M | $24M | $18M | $21M | $21M | $23M | $17M | |
| Interest Income | · | · | · | · | · | · | $9M | $1M | |
| Pretax Income | $-58M | $11M | $19M | $14M | $11M | $6M | $-9M | $-25M | |
| Income Tax | $1M | $4M | $-1M | $18M | $14M | $2M | $7M | $-11M | |
| Net Income | $-55M | $4M | $19M | $-7M | $-7M | $3M | $-18M | $-11M | |
| EPS (Basic) | $-0.88 | $0.07 | $0.30 | $-0.17 | $-0.18 | $0.09 | $-0.60 | $-0.39 | |
| EPS (Diluted) | $-0.88 | $0.07 | $0.30 | $-0.17 | $-0.18 | $0.09 | $-0.60 | $-0.39 | |
| Shares (Basic) | 63,228,240 | 62,840,129 | 62,146,082 | 42,302,318 | 39,218,632 | 36,120,447 | 30,478,390 | 28,098,117 | |
| Shares (Diluted) | 63,228,240 | 63,485,432 | 63,185,508 | 42,302,318 | 39,218,632 | 36,416,988 | 30,478,390 | 28,098,117 | |
| EBITDA | $-2M | $45M | $54M | $40M | $38M | $39M | $32M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $25M | $48M | $33M | $28M | $20M | $3M | $2M | |
| Receivables | · | $207M | $158M | $112M | $89M | $74M | $59M | $53M | |
| Inventory | $88M | $126M | $140M | $126M | $61M | $29M | $27M | $19M | |
| Current Assets | $308M | $409M | $397M | $298M | $211M | $165M | $98M | $85M | |
| PP&E (Net) | $75M | $75M | $68M | $50M | $48M | $42M | $44M | $40M | |
| Goodwill | $112M | $112M | $112M | $36M | $29M | $26M | $30M | $14M | |
| Intangibles | $181M | $177M | $174M | $77M | $67M | $35M | $40M | $27M | |
| Total Assets | $764M | $853M | $818M | $518M | $395M | $298M | $242M | $197M | |
| Accounts Payable | $96M | $169M | $151M | $126M | $72M | $57M | $41M | $28M | |
| Current Liabilities | $338M | $329M | $299M | $223M | $168M | $131M | $116M | $119M | |
| Total Liabilities | $468M | $501M | $488M | $360M | $304M | $237M | $180M | $164M | |
| Stockholders' Equity | $265M | $315M | $299M | $127M | $68M | $46M | $47M | $14M |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $50M | $42M | $3M | $-18M | $-6M | $9M | $30M | $18M | |
| CapEx | $6M | $10M | $11M | $3M | $3M | $2M | $2M | $3M | |
| Investing Cash Flow | $-6M | $-29M | $-26M | $3M | $-8M | $-8M | $-3M | $-8M | |
| Dividends Paid | $72.1K | $174.8K | $452.1K | · | · | · | · | · | |
| Financing Cash Flow | $-51M | $-10M | $33M | $15M | $7M | $34M | $-27M | $-10M | |
| Free Cash Flow | $44M | $32M | $-9M | $-21M | $-9M | $10M | $28M | · | |
| Levered FCF | $15M | $15M | $-34M | $-16M | $-1M | $-4M | $-18M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.3% | 40.1% | 43.4% | 37.8% | 43.4% | 45.9% | 45.9% | · | |
| Operating Margin | -0.67% | 9.6% | 13.0% | 11.9% | 18.3% | 22.6% | 20.0% | · | |
| Net Margin | -16.5% | 0.70% | 4.5% | -2.1% | -3.3% | 1.9% | -11.4% | · | |
| Pretax Margin | -17.2% | 2.2% | 4.6% | 4.2% | 5.0% | 3.7% | -5.8% | · | |
| EBITDA Margin | -0.67% | 9.6% | 13.0% | 11.9% | 18.3% | 22.6% | 20.0% | · | |
| ROA | -6.9% | 0.39% | 2.8% | -1.6% | -2.0% | 1.2% | -8.4% | · | |
| ROE | -19.1% | 1.1% | 8.8% | -7.4% | -12.1% | 7.2% | -60.2% | · | |
| ROIC | -0.86% | 8.9% | 19.2% | -8.7% | -20.6% | 55.7% | 118.4% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 1.2 | 1.3 | 1.3 | 1.3 | 1.3 | 0.8 | · | |
| Quick Ratio | 0.1 | 0.8 | 0.7 | 0.6 | 0.7 | 0.6 | 0.5 | · | |
| Interest Coverage | -0.1 | 1.7 | 2.3 | 2.2 | 1.8 | 1.9 | 1.2 | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.6 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | · | |
| Inventory Turnover | 1.9 | 2.1 | 1.8 | 2.2 | 2.6 | 3.3 | 3.7 | · | |
| Receivables Turnover | · | 2.5 | 3.1 | 3.3 | 2.6 | 2.6 | 2.9 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $5.30 | $7.32 | $6.58 | $7.91 | $5.34 | $4.75 | · | · | |
| Cash Flow / Share | $0.79 | $0.66 | $0.04 | $-0.41 | $-0.16 | $0.31 | · | · | |
| EPS (TTM) | $-0.88 | $0.07 | $0.30 | $-0.17 | $-0.18 | $0.09 | $-0.60 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $335M | $465M | $420M | $335M | $210M | $173M | $161M | · | |
| Net Income TTM | $-55M | $4M | $19M | $-7M | $-7M | $3M | $-18M | · | |
| P/E | -5.1 | 166.6 | 45.0 | -80.6 | -80.2 | 65.7 | -8.8 | · | |
| Earnings Yield | -19.6% | 0.60% | 2.2% | -1.2% | -1.2% | 1.5% | -11.4% | · | |
| Payout Ratio | -0.13% | 5.4% | 2.4% | · | · | · | · | · | |
| Annual Payout | $72.1K | $174.8K | $452.1K | · | · | · | · | · |
Tidak ada pengajuan triwulanan untuk BIOX
Kami belum memiliki pengajuan SEC untuk ticker ini.
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Pendapatan | $335M | $465M | $420M | $335M | $210M |
| Margin Kotor % | 39.3% | 40.1% | 43.4% | 37.8% | 43.4% |
| Margin Operasi % | -0.67% | 9.6% | 13.0% | 11.9% | 18.3% |
| Laba Bersih | $-55M | $4M | $19M | $-7M | $-7M |
| EPS Dilusian | $-0.88 | $0.07 | $0.30 | $-0.17 | $-0.18 |
| Metrik | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Rasio Lancar | 0.9 | 1.2 | 1.3 | 1.3 | 1.3 |
| Rasio Cepat | 0.1 | 0.8 | 0.7 | 0.6 | 0.7 |
| Metrik | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $44M | $32M | $-9M | $-21M | $-9M |
Pemilik institusional (13F) 32 pengaju · $3.0M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
32
Nilai yang dipegang
$3.0M
Posisi baru
5
Posisi yang keluar
6
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 5 (0 vs Kuartal sebelumnya) | 6 (-4 vs Kuartal sebelumnya) | 7 (-1 vs Kuartal sebelumnya) | 6 (+1 vs Kuartal sebelumnya) | -500K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Solel Partners LP | $1.603.235 | 4.579.364 | 52,77% | Saham |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $492.319 | 1.406.223 | 16,20% | Saham |
| Long Focus Capital Management, LLC | $290.495 | 829.748 | 9,56% | Saham |
| ARDSLEY ADVISORY PARTNERS LP | $166.298 | 475.000 | 5,47% | Saham |
| UBS Group AG | $142.897 | 408.276 | 4,70% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $74.547 | 212.930 | 2,45% | Saham |
| CITADEL ADVISORS LLC | $59.342 | 169.500 | 1,95% | Opsi beli |
| PNC Financial Services Group, Inc. | $46.550 | 133.000 | 1,53% | Saham |
| GOLDMAN SACHS GROUP INC | $45.319 | 129.445 | 1,49% | Saham |
| Cubist Systematic Strategies, LLC | $23.956 | 16.990 | 0,79% | Saham |
| PING CAPITAL MANAGEMENT, INC. | $19.256 | 55.000 | 0,63% | Saham |
| JANE STREET GROUP, LLC | $12.697 | 36.268 | 0,42% | Saham |
| TWO SIGMA INVESTMENTS, LP | $10.512 | 30.026 | 0,35% | Saham |
| PING CAPITAL MANAGEMENT, INC. | $10.503 | 30.000 | 0,35% | Opsi beli |
| STIFEL FINANCIAL CORP | $10.360 | 29.588 | 0,34% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $8.344 | 23.836 | 0,27% | Saham |
| MORGAN STANLEY | $6.306 | 18.014 | 0,21% | Saham |
| GROUP ONE TRADING LLC | $5.341 | 15.257 | 0,18% | Saham |
| CITADEL ADVISORS LLC | $4.061 | 11.600 | 0,13% | Opsi jual |
| Tower Research Capital LLC (TRC) | $3.342 | 9.547 | 0,11% | Saham |
| MJT & Associates Financial Advisory Group, Inc. | $521 | 1.487 | 0,02% | Saham |
| J.Safra Asset Management Corp | $490 | 1.400 | 0,02% | Saham |
| OSAIC HOLDINGS, INC. | $419 | 1.205 | 0,01% | Saham |
| SIMPLEX TRADING, LLC | $271 | 775 | 0,01% | Saham |
| EFG International AG | $263 | 750 | 0,01% | Saham |
| JONES FINANCIAL COMPANIES LLLP | $217 | 651 | 0,01% | Saham |
| HARBOUR INVESTMENTS, INC. | $123 | 352 | 0,00% | Saham |
| SBI Securities Co., Ltd. | $98 | 279 | 0,00% | Saham |
| Allworth Financial LP | $74 | 211 | 0,00% | Saham |
| JPMORGAN CHASE & CO | $10 | 29 | 0,00% | Saham |
| One Degree Advisors Inc | $7 | 23.038 | 0,00% | Saham |
| Caitong International Asset Management Co., Ltd | $0 | 1 | 0,00% | Saham |
Aktivis & pemilik 5%+ 7 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Agriculture Investment Group Corp., Granosur Holding Limited ×8 pengajuan | 7 Juli 2026 | 5,83% | Amandemen | · | SEC |
| Jasper Lake Ventures One LLC, Noah Kolatch ×4 pengajuan | 21 Jan. 2026 | 12,13% | Amandemen | · | SEC |
| Bioceres Group Limited, Bioceres LLC ×7 pengajuan | 28 Okt. 2025 | 10,00% | Amandemen | · | SEC |
| Bioceres Group PLC, Bioceres LLC, THEO I SCSp ×2 pengajuan | 20 Sep. 2024 | · | Pengajuan awal | · | SEC |
| Bioceres S.A., Bioceres LLC, THEO I SCSp | 17 Nov. 2022 | · | Pengajuan awal | · | SEC |
| Bioceres LLC, Bioceres S.A., THEO I SCSp ×8 pengajuan | 25 Juli 2022 | · | Pengajuan awal | · | SEC |
| DRACO Capital Investment Management Company S.A., 5D+ Draco I Latam Income Plus Segregated Portfolio, Biotech Investment Holding Ltd. ×2 pengajuan | 5 Agu 2021 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 2 orang dalam · 1 pejabat · 0 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Ezequiel Simmermacher | CFO | 3 Agu 2026 A | · | 0 | 0 | $0 |
| Federico Trucco | · | 20 Mei 2026 G | 130.000 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 1 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| ARGT · Global X Funds | 0,06% | 1.357.359 NS | 31 Juli 2026 | N-PORT |
BIOX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 6 analis
JUAL
0 0,0%
Beli Kuat
0 0,0%
Beli
3 50,0%
Tahan
1 16,7%
Jual
2 33,3%
Jual Kuat
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 20-F diajukan Nov 10, 2025